Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: A review of emerging challenges

The Lancet Infectious Diseases

Volumn 14, Issue 7, 2014, Pages 627-639

  Lowenthal, Elizabeth D ^a,b,c   Bakeera Kitaka, Sabrina ^d   Marukutira, Tafireyi ^e   Chapman, Jennifer ^b   Goldrath, Kathryn ^a   Ferrand, Rashida A ^f,g  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c BOTSWANA UPENN PARTNERSHIP   (Botswana)

^d MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^e Princess Marina Hospital   (Botswana)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g BIOMEDICAL RESEARCH AND TRAINING INSTITUTE   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; TENOFOVIR;

ADOLESCENT; AFRICA SOUTH OF THE SAHARA; BONE DISEASE; BRAIN DISEASE; CHRONIC DISEASE; CHRONIC LUNG DISEASE; DISEASE COURSE; DISEASE SEVERITY; GROWTH DISORDER; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH EDUCATION; HEART DISEASE; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICATION COMPLIANCE; MORBIDITY; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; REVIEW; SEXUAL HEALTH; SKIN DISEASE; SOCIAL PSYCHOLOGY; VERTICAL TRANSMISSION; AGE; CANDIDIASIS; CONGESTIVE CARDIOMYOPATHY; DISEASE TRANSMISSION; ENVIRONMENTAL FACTOR; FAILURE TO THRIVE; HEALTH SERVICE; HIV ASSOCIATED DEMENTIA; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MEDICAL RESEARCH; PERICARDIAL EFFUSION; PHYSICAL DEVELOPMENT; PNEUMOCYSTIS PNEUMONIA; SEXUALITY; SOCIAL WORK;

ADOLESCENT; AFRICA SOUTH OF THE SAHARA; DELIVERY OF HEALTH CARE; HIV; HIV INFECTIONS; HUMANS; SEXUAL BEHAVIOR;

EID: 84904740904     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70363-3     Document Type: Review

References (161)

1. UNAIDS report on the global AIDS epidemic 2013 Joint United Nations Programme on HIV/AIDS (UNAIDS), (accessed Nov 28, 2013). http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.
2. Dabis F, Ekpini ER HIV-1/AIDS and maternal and child health in Africa. Lancet 2002, 359:2097-2104.
3. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector-progress report 2010 WHO, UNAIDSUNAIDS, UNICEFUNICEF, (accessed Nov 28, 2013). http://whqlibdoc.who.int/publications/2010/9789241500395_eng.pdf.
4. Hazra R, Siberry GK, Mofenson LM Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection. Annu Rev Med 2010, 61:169-185.
5. Sohn AH, Hazra R The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents. J Int AIDS Soc 2013, 16:18555.
6. Newell M-L, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004, 364:1236-1243. for the Ghent International AIDS Society (IAS) working group on HIV infection in women and children.
7. Fatti G, Bock P, Eley B, Mothibi E, Grimwood A Temporal trends in baseline characteristics and treatment outcomes of children starting antiretroviral treatment: an analysis in four provinces in South Africa, 2004-2009. J Acquir Immune Defic Syndr 2011, 58:e60-e67.
8. van Dijk JH, Sutcliffe CG, Munsanje B, et al. HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy. PLoS One 2011, 6:e19006.
9. Ferrand R, Lowe S, Whande B, et al. Survey of children accessing HIV services in a high prevalence setting: time for adolescents to count?. Bull World Health Organ 2010, 88:428-434.
10. Ferrand RA, Luethy R, Bwakura F, Mujuru H, Miller RF, Corbett EL HIV infection presenting in older children and adolescents: a case series from Harare, Zimbabwe. Clin Infect Dis 2007, 44:874-878.
11. Walker AS, Mulenga V, Sinyinza F, et al. Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP trial. J Acquir Immune Defic Syndr 2006, 42:637-645. the CHAP trial team.
12. Ferrand RA, Corbett EL, Wood R, et al. AIDS among older children and adolescents in southern Africa: projecting the time course and magnitude of the epidemic. AIDS 2009, 23:2039-2046.
13. Marston M, Becquet R, Zaba B, et al. Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol 2011, 40:385-396.
14. Gray L, Newell ML, Thorne C, Peckham C, Levy J Fluctuations in symptoms in human immunodeficiency virus-infected children: the first 10 years of life. Pediatrics 2001, 108:116-122. the European Collaborative Study.
15. Commenges D, Alioum A, Lepage P, Van de Perre P, Msellati P, Dabis F Estimating the incubation period of paediatric AIDS in Rwanda. AIDS 1992, 6:1515-1520.
16. Brookes H, Shisana O, Richter L The national household HIV prevalence and risk survey of South African children 2004, Human Social Research Council, Cape Town.
17. Second Botswana AIDS Impact Survey (BAIS II) 2005, National AIDS Coordinating Agency, Government of Botswana, Botswana.
18. Gomo E, Rusakaniko S, Mashange W, Mutswanga J, Chandiwana B, Munyati S Household survey of HIV-prevalence and behaviour in Chimanimani District, Zimbabwe 2005, Human Social Research Council, Cape Town.
19. Gregson S, Nyamukapa CA, Garnett GP, et al. Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet 2002, 359:1896-1903.
20. Blokzijl ML Human immunodeficiency virus infection in childhood. Ann Trop Paediatr 1988, 8:1-17.
21. Ferrand RA, Munaiwa L, Matsekete J, et al. Undiagnosed HIV infection among adolescents seeking primary health care in Zimbabwe. Clin Infect Dis 2010, 51:844-851.
22. Harrison A, Pierre RB, Palmer P, et al. Clinical manifestations of adolescents with HIV/AIDS in Jamaica. West Indian Med J 2008, 57:257-264.
23. Marais BJ, Gie RP, Hesseling AH, Beyers N Adult-type pulmonary tuberculosis in children 10-14 years of age. Pediatr Infect Dis J 2005, 24:743-744.
24. Ferrand RA, Bandason T, Musvaire P, et al. Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: a prospective survey. PLoS Med 2010, 7:e1000178.
25. Meiring ST, Quan VC, Cohen C, et al. A comparison of cases of paediatric-onset and adult-onset cryptococcosis detected through population-based surveillance, 2005-2007. AIDS 2012, 26:2307-2314. the Group for Enteric, Respiratory and Meningeal disease Surveillance in South Africa (GERMS-SA)Respiratory and Meningeal disease Surveillance in South Africa (GERMS-SA).
26. Marais BJ, Gie RP, Schaaf HS, et al. The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004, 8:278-285.
27. Wood R, Racow K, Bekker LG, et al. Indoor social networks in a South African township: potential contribution of location to tuberculosis transmission. PLoS One 2012, 7:e39246.
28. Perez-Velez CM, Marais BJ Tuberculosis in children. N Engl J Med 2012, 367:348-361.
29. Ferrand RA, Desai SR, Hopkins C, et al. Chronic lung disease in adolescents with delayed diagnosis of vertically acquired HIV infection. Clin Infect Dis 2012, 55:145-152.
30. Morris L, Posada R, Hickman C, et al. Susceptibility to measles among perinatally HIV-infected adolescents and young adults. Presented at AIDS 2012, the XIX International AIDS Conference; Washington, DC, USA (accessed Nov 28, 2013). http://pag.aids2012.org/EPosterHandler.axd?aid=14088.
31. Moss WJ, Scott S, Mugala N, et al. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study. J Infect Dis 2007, 196:347-355.
32. Aurpibul L, Puthanakit T, Sirisanthana T, Sirisanthana V Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy. Clin Infect Dis 2007, 45:637-642.
33. L'Huillier AG, Ferry T, Courvoisier DS, et al. Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity. HIV Med 2012, 13:54-61. the Pediatric Infectious Diseases Group of Switzerland, the Group of Switzerland (PIGS)the Group of Switzerland (PIGS), the Swiss HIV Cohort Study (SHCS)the Swiss HIV Cohort Study (SHCS), the Swiss Mother & Child HIV Cohort Study (MoCHiV)the Swiss Mother & Child HIV Cohort Study (MoCHiV).
34. Wolf ER, Wirth KE, Ho-Foster A, et al. The effect of measles on disease markers in HIV + children and adolescents living in Botswana. Presented at AIDS 2012, the XIX International AIS Conference; Washington, DC, USA (accessed Nov 28, 2013). http://pag.aids2012.org/EPosterHandler.axd?aid=14589.
35. Mutwa PR, Boer KR, Rusine JB, et al. Hepatitis B virus prevalence and vaccine response in HIV-infected children and adolescents on combination antiretroviral therapy in Kigali, Rwanda. Pediatr Infect Dis J 2013, 32:246-251.
36. van Bogaert LJ Age at diagnosis of preinvasive and invasive cervical neoplasia in South Africa: HIV-positive versus HIV-negative women. Int J Gynecol Cancer 2011, 21:363-366.
37. Watson-Jones D, Baisley K, Brown J, et al. High prevalence and incidence of human papillomavirus in a cohort of healthy young African female subjects. Sex Transm Infect 2013, 89:358-365.
38. Katz IT, Nkala B, Dietrich J, et al. A qualitative analysis of factors influencing HPV vaccine uptake in Soweto, South Africa among adolescents and their caregivers. PLoS One 2013, 8:e72094.
39. Firnhaber C, Wilkin T Human papillomavirus vaccines: where do they fit in HIV-infected individuals?. Curr HIV/AIDS Rep 2012, 9:278-286.
40. Serraino D, Franceschi S Kaposi's sarcoma and non-Hodgkin's lymphomas in children and adolescents with AIDS. AIDS 1996, 10:643-647.
41. Athale UH, Patil PS, Chintu C, Elem B Influence of HIV epidemic on the incidence of Kaposi's sarcoma in Zambian children. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 8:96-100.
42. Tukei VJ, Kekitiinwa A, Beasley RP Prevalence and outcome of HIV-associated malignancies among children. AIDS 2011, 25:1789-1793.
43. Gantt S, Kakuru A, Wald A, et al. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children. Pediatr Blood Cancer 2010, 54:670-674.
44. Mueller BU Cancers in children infected with the human immunodeficiency virus. Oncologist 1999, 4:309-317.
45. Moore SW, Davidson A, Hadley GP, et al. Malignant liver tumors in South African children: a national audit. World J Surg 2008, 32:1389-1395.
46. Ramdial PK, Sing Y, Deonarain J, Hadley GP, Singh B Dermal Epstein Barr virus-associated leiomyosarcoma: tocsin of acquired immunodeficiency syndrome in two children. Am J Dermatopathol 2011, 33:392-396.
47. Mangeya N, Mafukidze AT, Pascoe M, et al. Cholangiocarcinoma presenting in an adolescent with vertically acquired HIV infection. Int J STD AIDS 2008, 19:717-718.
48. Jeena PM, Coovadia HM, Thula SA, Blythe D, Buckels NJ, Chetty R Persistent and chronic lung disease in HIV-1 infected and uninfected African children. AIDS 1998, 12:1185-1193.
49. Zar HJ Chronic lung disease in human immunodeficiency virus (HIV) infected children. Pediatr Pulmonol 2008, 43:1-10.
50. Sharland M, Gibb DM, Holland F Respiratory morbidity from lymphocytic interstitial pneumonitis (LIP) in vertically acquired HIV infection. Arch Dis Child 1997, 76:334-336.
51. Weber HC, Gie RP, Cotton MF The challenge of chronic lung disease in HIV-infected children and adolescents. J Int AIDS Soc 2013, 16:18633.
52. Rylance J, Mwalukomo T, Rylance S, et al. Lung function and bronchodilator response in perinatally HIV-infected Malawian adolescents. Presented at the 19th Conference on Retroviruses and Opportunistic Infections; Seattle, WA, USA; March 5-8, 2012.
53. Lynch JP, Weigt SS, DerHovanessian A, Fishbein MC, Gutierrez A, Belperio JA Obliterative (constrictive) bronchiolitis. Semin Respir Crit Care Med 2012, 33:509-532.
54. Colom AJ, Teper AM, Vollmer WM, Diette GB Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax 2006, 61:503-506.
55. Lubega S, Zirembuzi GW, Lwabi P Heart disease among children with HIV/AIDS attending the paediatric infectious disease clinic at Mulago Hospital. Afr Health Sci 2005, 5:219-226.
56. Okoromah CA, Ojo OO, Ogunkunle OO Cardiovascular dysfunction in HIV-infected children in a sub-Saharan African country: comparative cross-sectional observational study. J Trop Pediatr 2012, 58:3-11.
57. Brown SC, Schoeman CJ, Bester CJ Cardiac findings in children admitted to a hospital general ward in South Africa: a comparison of HIV-infected and uninfected children. Cardiovasc J S Afr 2005, 16:206-210.
58. Lipshultz SE, Miller TL, Wilkinson JD, et al. Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America. J Int AIDS Soc 2013, 16:18597.
59. Miller RF, Kaski JP, Hakim J, et al. Cardiac disease in adolescents with delayed diagnosis of vertically-acquired HIV infection. Clin Infect Dis 2013, 56:576-582.
60. Barlow-Mosha L, Eckard AR, McComsey GA, Musoke PM Metabolic complications and treatment of perinatally HIV-infected children and adolescents. J Int AIDS Soc 2013, 16:18600.
61. Buchacz K, Rogol AD, Lindsey JC, et al. Delayed onset of pubertal development in children and adolescents with perinatally acquired HIV infection. J Acquir Immune Defic Syndr 2003, 33:56-65. the Pediatric AIDS Clinical Trials Group 219 Study Team.
62. de Martino M, Tovo PA, Galli L, et al. Puberty in perinatal HIV-1 infection: a multicentre longitudinal study of 212 children. AIDS 2001, 15:1527-1534. the Italian Register for HIV infection in Children.
63. Majaliwa ES, Mohn A, Chiarelli F Growth and puberty in children with HIV infection. J Endocrinol Invest 2009, 32:85-90.
64. Williams PL, Abzug MJ, Jacobson DL, et al. Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment. AIDS 2013, 27:1959-1970. the International Maternal Pediatric and Adolescent AIDS Clinical Trials P219219C Study, the Pediatric HIVAIDS Cohort Studythe Pediatric HIVAIDS Cohort Study.
65. Arpadi SM Growth failure in children with HIV infection. J Acquir Immune Defic Syndr 2000, 25(suppl 1):S37-S42.
66. Kekitiinwa A, Lee KJ, Walker AS, et al. Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr 2008, 49:384-392. the Collaborative HIV Paediatric Study (CHIPS) Steering Committe, the Mulago Cohort Teamthe Mulago Cohort Team.
67. Gsponer T, Weigel R, Davies MA, et al. Variability of growth in children starting antiretroviral treatment in southern Africa. Pediatrics 2012, 130:e966-e977. the IeDEA Southern Africa.
68. Bakeera-Kitaka S, McKellar M, Snider C, et al. Antiretroviral therapy for HIV-1 infected adolescents in Uganda: assessing the impact on growth and sexual maturation. J Pediatr Infect Dis 2008, 3:97-104. (accessed Nov 28, 2013). http://iospress.metapress.com/content/j668135704616802/.
69. Bagenda D, Nassali A, Kalyesubula I, et al. Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children. Pediatrics 2006, 117:729-740.
70. Laughton B, Cornell M, Boivin M, Van Rie A Neurodevelopment in perinatally HIV-infected children: a concern for adolescence. J Int AIDS Soc 2013, 16:18603.
71. Laughton B, Cornell M, Grove D, et al. Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS 2012, 26:1685-1690.
72. Puthanakit T, Ananworanich J, Vonthanak S, et al. Cognitive function and neurodevelopmental outcomes in HIV-infected children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study. Pediatr Infect Dis J 2013, 32:501-508. the PREDICT Study Group.
73. Le Doaré K, Bland R, Newell ML Neurodevelopment in children born to HIV-infected mothers by infection and treatment status. Pediatrics 2012, 130:e1326-e1344.
74. Puthanakit T, Aurpibul L, Louthrenoo O, et al. Poor cognitive functioning of school-aged children in thailand with perinatally acquired HIV infection taking antiretroviral therapy. AIDS Patient Care STDS 2010, 24:141-146.
75. Lowe S, Ferrand RA, Morris-Jones R, et al. Skin disease among human immunodeficiency virus-infected adolescents in Zimbabwe: a strong indicator of underlying HIV infection. Pediatr Infect Dis J 2010, 29:346-351.
76. Lowe SM, Katsidzira L, Meys R, et al. Acquired epidermodysplasia verruciformis due to multiple and unusual HPV infection among vertically-infected, HIV-positive adolescents in Zimbabwe. Clin Infect Dis 2012, 54:e119-e123.
77. Moore RL, de Schaetzen V, Joseph M, et al. Acquired epidermodysplasia verruciformis syndrome in HIV-infected pediatric patients: prospective treatment trial with topical glycolic acid and human papillomavirus genotype characterization. Arch Dermatol 2012, 148:128-130.
78. Seoane Reula E, Bellon JM, Gurbindo D, Muñoz-Fernandez MA Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades. Br J Dermatol 2005, 153:382-389.
79. Amerson EH, Maurer TA Immune reconstitution inflammatory syndrome and tropical dermatoses. Dermatol Clin 2011, 29:39-43.
80. Bhimma R, Purswani MU, Kala U Kidney disease in children and adolescents with perinatal HIV-1 infection. J Int AIDS Soc 2013, 16:18596.
81. Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010, 329:841-845.
82. Arpadi SM, Horlick M, Thornton J, Cuff PA, Wang J, Kotler DP Bone mineral content is lower in prepubertal HIV-infected children. J Acquir Immune Defic Syndr 2002, 29:450-454.
83. O'Brien KO, Razavi M, Henderson RA, Caballero B, Ellis KJ Bone mineral content in girls perinatally infected with HIV. Am J Clin Nutr 2001, 73:821-826.
84. Puthanakit T, Siberry GK Bone health in children and adolescents with perinatal HIV infection. J Int AIDS Soc 2013, 16:18575.
85. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach WHO, (accessed Nov 28, 2013). http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf.
86. Innes S, Cotton MF, Haubrich R, et al. High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study. BMC Pediatr 2012, 12:183.
87. Lipshultz SE, Williams PL, Wilkinson JD, et al. Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study. JAMA Pediatr 2013, 167:520-527. the Pediatric HIV/AIDS Cohort Study (PHACS).
88. Technical update on treatment optimization: use of tenofovir in HIV-infected children and adolescents-a public health perspective WHO, HIV/AIDS ProgrammeHIV/AIDS Programme, (accessed Nov 28, 2013). http://apps.who.int/iris/bitstream/10665/70944/1/9789241503822_eng.pdf.
89. Rakhmanina NY, van den Anker JN, Soldin SJ, van Schaik RH, Mordwinkin N, Neely MN Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?. Ther Drug Monit 2010, 32:273-281.
90. Nyamukapa CA, Gregson S, Lopman B, et al. HIV-associated orphanhood and children's psychosocial distress: theoretical framework tested with data from Zimbabwe. Am J Public Health 2008, 98:133-141.
91. Petersen I, Bhana A, Myeza N, et al. Psychosocial challenges and protective influences for socio-emotional coping of HIV+ adolescents in South Africa: a qualitative investigation. AIDS Care 2010, 22:970-978.
92. Bachmann MO, Booysen FL Health and economic impact of HIV/AIDS on South African households: a cohort study. BMC Public Health 2003, 3:14.
93. Children on the brink 2004: a joint report of new orphan estimates and a framework for action UNAIDS, UNICEFUNICEF, USAIDUSAID, (accessed Nov 28, 2013). http://www.unicef.org/publications/cob_layout6-013.pdf.
94. Monasch R, Boerma JT Orphanhood and childcare patterns in sub-Saharan Africa: an analysis of national surveys from 40 countries. AIDS 2004, 18(suppl 2):S55-S65.
95. Gregson S, Nyamukapa CA, Garnett GP, et al. HIV infection and reproductive health in teenage women orphaned and made vulnerable by AIDS in Zimbabwe. AIDS Care 2005, 17:785-794.
96. Nyamukapa CA, Gregson S, Wambe M, et al. Causes and consequences of psychological distress among orphans in eastern Zimbabwe. AIDS Care 2010, 22:988-996.
97. Nyamukapa C, Gregson S Extended family's and women's roles in safeguarding orphans' education in AIDS-afflicted rural Zimbabwe. Soc Sci Med 2005, 60:2155-2167.
98. Cluver L, Orkin M, Boyes M, Gardner F, Meinck F Transactional sex amongst AIDS-orphaned and AIDS-affected adolescents predicted by abuse and extreme poverty. J Acquir Immune Defic Syndr 2011, 58:336-343.
99. Cluver LD, Orkin M, Gardner F, Boyes ME Persisting mental health problems among AIDS-orphaned children in South Africa. J Child Psychol Psychiatry 2012, 53:363-370.
100. Cohen J, Reddington C, Jacobs D, et al. School-related issues among HIV-infected children. Pediatrics 1997, 100:E8.
101. Cluver L, Bowes L, Gardner F Risk and protective factors for bullying victimization among AIDS-affected and vulnerable children in South Africa. Child Abuse Negl 2010, 34:793-803.
102. Gaughan DM, Hughes MD, Oleske JM, Malee K, Gore CA, Nachman S Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection. Pediatrics 2004, 113:e544-e551. the Pediatric AIDS Clinical Trials Group 219C Team.
103. Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ Psychiatric disorders in youth with perinatally acquired human immunodeficiency virus infection. Pediatr Infect Dis J 2006, 25:432-437.
104. Mellins CA, Malee KM Understanding the mental health of youth living with perinatal HIV infection: lessons learned and current challenges. J Int AIDS Soc 2013, 16:18593.
105. Betancourt TS, Rubin-Smith JE, Beardslee WR, Stulac SN, Fayida I, Safren S Understanding locally, culturally, and contextually relevant mental health problems among Rwandan children and adolescents affected by HIV/AIDS. AIDS Care 2011, 23:401-412.
106. Langhaug LF, Pascoe SJ, Mavhu W, et al. High prevalence of affective disorders among adolescents living in rural Zimbabwe. J Community Health 2010, 35:355-364.
107. Cluver L, Gardner F, Operario D Poverty and psychological health among AIDS-orphaned children in Cape Town, South Africa. AIDS Care 2009, 21:732-741.
108. Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2004, 23:1035-1041.
109. Nyandiko WM, Ayaya S, Nabakwe E, et al. Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya. J Acquir Immune Defic Syndr 2006, 43:418-425.
110. Borus JS, Laffel L Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention. Curr Opin Pediatr 2010, 22:405-411.
111. Desai M, Oppenheimer JJ Medication adherence in the asthmatic child and adolescent. Curr Allergy Asthma Rep 2011, 11:454-464.
112. Shroufi A, Gunguwo H, Dixon M, et al. HIV-infected adolescents in southern Africa can achieve good treatment outcomes: results from a retrospective cohort study. AIDS 2013, 27:1971-1978.
113. Nachega JB, Hislop M, Nguyen H, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr 2009, 51:65-71.
114. Bygrave H, Mtangirwa J, Ncube K, Ford N, Kranzer K, Munyaradzi D Antiretroviral therapy outcomes among adolescents and youth in rural Zimbabwe. PLoS One 2012, 7:e52856.
115. Evans D, Menezes C, Mahomed K, et al. Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa. AIDS Res Hum Retroviruses 2013, 29:892-900.
116. Bakanda C, Birungi J, Mwesigwa R, et al. Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda. PLoS One 2011, 6:e19261.
117. Charles M, Noel F, Leger P, et al. Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals. Bull World Health Organ 2008, 86:970-977.
118. Haberer JE, Cook A, Walker AS, et al. Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects. PLoS One 2011, 6:e18505.
119. Biadgilign S, Deribew A, Amberbir A, Deribe K Barriers and facilitators to antiretroviral medication adherence among HIV-infected paediatric patients in Ethiopia: a qualitative study. SAHARA J 2009, 6:148-154.
120. Nabukeera-Barungi N, Kalyesubula I, Kekitiinwa A, Byakika-Tusiime J, Musoke P Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala. Ann Trop Paediatr 2007, 27:123-131.
121. Bikaako-Kajura W, Luyirika E, Purcell DW, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav 2006, 10(suppl):S85-S93.
122. Hodgson I, Ross J, Haamujompa C, Gitau-Mburu D Living as an adolescent with HIV in Zambia: lived experiences, sexual health and reproductive needs. AIDS Care 2012, 24:1204-1210.
123. Vijayan T, Benin AL, Wagner K, Romano S, Andiman WA We never thought this would happen: transitioning care of adolescents with perinatally acquired HIV infection from pediatrics to internal medicine. AIDS Care 2009, 21:1222-1229.
124. Attia S, Egger M, Müller M, Zwahlen M, Low N Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009, 23:1397-1404.
125. Levine AB, Aaron E, Foster J Pregnancy in perinatally HIV-infected adolescents. J Adolesc Health 2006, 38:765-768.
126. Rice E, Batterham P, Rotheram-Borus MJ Unprotected sex among youth living with HIV before and after the advent of highly active antiretroviral therapy. Perspect Sex Reprod Health 2006, 38:162-167.
127. Bearinger LH, Sieving RE, Ferguson J, Sharma V Global perspectives on the sexual and reproductive health of adolescents: patterns, prevention, and potential. Lancet 2007, 369:1220-1231.
128. Fatusi A, Blum RW Adolescent health in an international context: the challenge of sexual and reproductive health in sub-Saharan Africa. Adolesc Med State Art Rev 2009, 20:874-886.
129. Birungi H, Mugisha J, Nyombi J, Obare F, Evelia H, Nyinkavu H Sexual and reproductive health needs of adolescents perinatally infected with HIV in Uganda (accessed Nov 28, 2013). http://www.popcouncil.org/pdfs/frontiers/FR_FinalReports/Uganda_HIV.pdf.
130. Bakeera-Kitaka S, Nabukeera-Barungi N, Nöstlinger C, Addy K, Colebunders R Sexual risk reduction needs of adolescents living with HIV in a clinical care setting. AIDS Care 2008, 20:426-433.
131. Cherie A, Berhane Y Oral and anal sex practices among high school youth in Addis Ababa, Ethiopia. BMC Public Health 2012, 12:5.
132. Kazaura MR, Masatu MC Sexual practices among unmarried adolescents in Tanzania. BMC Public Health 2009, 9:373.
133. Birungi H, Mugisha JF, Obare F, Nyombi JK Sexual behavior and desires among adolescents perinatally infected with human immunodeficiency virus in Uganda: implications for programming. J Adolesc Health 2009, 44:184-187.
134. Siu GE, Bakeera-Kitaka S, Kennedy CE, Dhabangi A, Kambugu A HIV serostatus disclosure and lived experiences of adolescents at the Transition Clinic of the Infectious Diseases Clinic in Kampala, Uganda: a qualitative study. AIDS Care 2012, 24:606-611.
135. Obare F, van der Kwaak A, Birungi H Factors associated with unintended pregnancy, poor birth outcomes and post-partum contraceptive use among HIV-positive female adolescents in Kenya. BMC Womens Health 2012, 12:34.
136. Birungi H, Obare F, Mugisha JF, Evelia H, Nyombi J Preventive service needs of young people perinatally infected with HIV in Uganda. AIDS Care 2009, 21:725-731.
137. Phillips SJ, Curtis KM, Polis CB Effect of hormonal contraceptive methods on HIV disease progression: a systematic review. AIDS 2013, 27:787-794.
138. Belzer M, Rogers AS, Camarca M, et al. Contraceptive choices in HIV infected and HIV at-risk adolescent females. J Adolesc Health 2001, 29(suppl):93-100. the Adolescent Medicine HIV/AIDS Research Network.
139. Biadgilign S, Deribew A, Amberbir A, Escudero HR, Deribe K Factors associated with HIV/AIDS diagnostic disclosure to HIV infected children receiving HAART: a multi-center study in Addis Ababa, Ethiopia. PLoS One 2011, 6:e17572.
140. Kallem S, Renner L, Ghebremichael M, Paintsil E Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana. AIDS Behav 2011, 15:1121-1127.
141. Domek GJ Social consequences of antiretroviral therapy: preparing for the unexpected futures of HIV-positive children. Lancet 2006, 367:1367-1369.
142. Ferris M, Burau K, Schweitzer AM, et al. The influence of disclosure of HIV diagnosis on time to disease progression in a cohort of Romanian children and teens. AIDS Care 2007, 19:1088-1094.
143. Lee MB, Rotheram-Borus MJ Parents' disclosure of HIV to their children. AIDS 2002, 16:2201-2207.
144. Williams PL, Storm D, Montepiedra G, et al. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics 2006, 118:e1745-e1757.
145. Menon A, Glazebrook C, Campain N, Ngoma M Mental health and disclosure of HIV status in Zambian adolescents with HIV infection: implications for peer-support programs. J Acquir Immune Defic Syndr 2007, 46:349-354.
146. Vaz L, Corneli A, Dulyx J, et al. The process of HIV status disclosure to HIV-positive youth in Kinshasa, Democratic Republic of the Congo. AIDS Care 2008, 20:842-852.
147. Wood K, Chase E, Aggleton P 'Telling the truth is the best thing': teenage orphans' experiences of parental AIDS-related illness and bereavement in Zimbabwe. Soc Sci Med 2006, 63:1923-1933.
148. Kouyoumdjian FG, Meyers T, Mtshizana S Barriers to disclosure to children with HIV. J Trop Pediatr 2005, 51:285-287.
149. Moodley K, Myer L, Michaels D, Cotton M Paediatric HIV disclosure in South Africa: caregivers' perspectives on discussing HIV with infected children. S Afr Med J 2006, 96:201-204.
150. Vreeman RC, Nyandiko WM, Ayaya SO, Walumbe EG, Marrero DG, Inui TS The perceived impact of disclosure of pediatric HIV status on pediatric antiretroviral therapy adherence, child well-being, and social relationships in a resource-limited setting. AIDS Patient Care STDS 2010, 24:639-649.
151. Brown BJ, Oladokun RE, Osinusi K, Ochigbo S, Adewole IF, Kanki P Disclosure of HIV status to infected children in a Nigerian HIV Care Programme. AIDS Care 2011, 23:1053-1058.
152. Myer L, Moodley K, Hendricks F, Cotton M Healthcare providers' perspectives on discussing HIV status with infected children. J Trop Pediatr 2006, 52:293-295.
153. Guideline on HIV disclosure counselling for children up to 12 years of age WHO, (accessed Nov 28, 2013). http://whqlibdoc.who.int/publications/2011/9789241502863_eng.pdf.
154. Vaz LM, Eng E, Maman S, Tshikandu T, Behets F Telling children they have HIV: lessons learned from findings of a qualitative study in sub-Saharan Africa. AIDS Patient Care STDS 2010, 24:247-256.
155. Ferguson J, Baggaley R, Pazvakavambwa B, Ncube B, Desta Woldehanna T, Hirnschall G WHO guidelines on HIV testing and counselling for adolescents and care for adolescents living with HIV. Presented at the 7th International AIDS Society Conference; Kuala Lumpur, Malaysia the WHO Adolescent HIV Guidelines Development Group, (accessed Nov 28, 2013). http://www.who.int/hiv/events/2013/IAS_poster_01_htc.pdf.pdf.
156. Annex 14: strengthening health services and outcomes for adolescents living with HIV. HIV and adolescents: guidance for HIV testing and counselling and care for adolescents living with HIV-recommendations for a public health approach and considerations for policy-makers and managers 2013, WHO, World Health Organization, Geneva.
157. Ferrand RA, Weiss HA, Nathoo K, et al. A primary care level algorithm for identifying HIV-infected adolescents in populations at high risk through mother-to-child transmission. Trop Med Int Health 2011, 16:349-355.
158. Patten GE, Wilkinson L, Conradie K, et al. Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South Africa. J Int AIDS Soc 2013, 16:18518.
159. Dowshen N, Kuhns LM, Johnson A, Holoyda BJ, Garofalo R Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders. J Med Internet Res 2012, 14:e51.
160. Gross R, Bellamy SL, Chapman J, et al. Managed problem solving for antiretroviral therapy adherence: a randomized trial. JAMA Intern Med 2013, 173:300-306.
161. Boon-Yasidhi V, Chokephaibulkit K, McConnell MS, et al. Development of a diagnosis disclosure model for perinatally HIV-infected children in Thailand. AIDS Care 2013, 25:756-762.